RGD Reference Report - Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1α. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1α.

Authors: Zhu, Lili  Wang, Lei  Cao, Fei  Liu, Peng  Bao, Haidong  Yan, Yumei  Dong, Xin  Wang, Dong  Wang, Zhongyu  Gong, Peng 
Citation: Zhu L, etal., J Hepatobiliary Pancreat Sci. 2018 Mar;25(3):195-205. doi: 10.1002/jhbp.537.
RGD ID: 14995480
Pubmed: PMID:29360226   (View Abstract at PubMed)
DOI: DOI:10.1002/jhbp.537   (Journal Full-text)


BACKGROUND: The purpose of the present study was to investigate the effect and potential mechanism of chlorogenic acid (CA) on liver injury induced by cholestasis in a rat model of bile duct ligation (BDL).
METHODS: Rats received vehicle or CA (20, 50, or 100 mg/kg per day) orally for 3 days. On the 4th day, the rats underwent sham or BDL surgery, and were orally administrated vehicle or CA for 3 or 7 days. mRNA and protein expression levels were evaluated by qRT-PCR and western blot.
RESULTS: After BDL, plasma levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and total bile acids (TBA) were increased and typical pathological changes were observed in liver morphology. Hepatic uptake transporters (Ntcp, Oatp 1a4, and Oatp 1b2) were downregulated, while efflux transporters (Bsep and Mrp 2/3/4) were upregulated. BDL inhibited the expressions of Cyp7a1, Cyp8b1, and Cyp27a1 and induced Ugt1a1. CA treatment decreased ALT, AST, TBIL, and TBA (P < 0.05) and alleviated the liver pathological changes. The degree of expression changes in the transporters and enzymes was extended by CA (P < 0.05). SIRT1 protein was induced after CA treatment in BDL rats.
CONCLUSIONS: Chlorogenic acid attenuated hepatotoxicity and cholestasis by decreasing the uptake and synthesis of bilirubin and bile acids and accelerating the metabolism and efflux of bilirubin and bile acids.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
ABCC4Humanextrahepatic cholestasis treatmentISOAbcc4 (Rattus norvegicus)mRNA:increased expression:liver (rat)RGD 
Abcc4Ratextrahepatic cholestasis treatmentIEP mRNA:increased expression:liver (rat)RGD 
Abcc4Mouseextrahepatic cholestasis treatmentISOAbcc4 (Rattus norvegicus)mRNA:increased expression:liver (rat)RGD 
CYP27A1Humanextrahepatic cholestasis treatmentISOCyp27a1 (Rattus norvegicus)mRNA:decreased expression:liver (rat)RGD 
CYP7A1Humanextrahepatic cholestasis treatmentISOCyp7a1 (Rattus norvegicus)mRNA:decreased expression:liver (rat)RGD 
CYP8B1Humanextrahepatic cholestasis treatmentISOCyp8b1 (Rattus norvegicus)mRNA:decreased expression:liver (rat)RGD 
Cyp27a1Ratextrahepatic cholestasis treatmentIEP mRNA:decreased expression:liver (rat)RGD 
Cyp27a1Mouseextrahepatic cholestasis treatmentISOCyp27a1 (Rattus norvegicus)mRNA:decreased expression:liver (rat)RGD 
Cyp7a1Ratextrahepatic cholestasis treatmentIEP mRNA:decreased expression:liver (rat)RGD 
Cyp7a1Mouseextrahepatic cholestasis treatmentISOCyp7a1 (Rattus norvegicus)mRNA:decreased expression:liver (rat)RGD 
Cyp8b1Ratextrahepatic cholestasis treatmentIEP mRNA:decreased expression:liver (rat)RGD 
Cyp8b1Mouseextrahepatic cholestasis treatmentISOCyp8b1 (Rattus norvegicus)mRNA:decreased expression:liver (rat)RGD 
NR1H4Humanextrahepatic cholestasis treatmentISONr1h4 (Rattus norvegicus)mRNA:increased expression:liver (rat)RGD 
Nr1h4Ratextrahepatic cholestasis treatmentIEP mRNA:increased expression:liver (rat)RGD 
Nr1h4Mouseextrahepatic cholestasis treatmentISONr1h4 (Rattus norvegicus)mRNA:increased expression:liver (rat)RGD 

Objects Annotated

Genes (Rattus norvegicus)
Abcc4  (ATP binding cassette subfamily C member 4)
Cyp27a1  (cytochrome P450, family 27, subfamily a, polypeptide 1)
Cyp7a1  (cytochrome P450 family 7 subfamily A member 1)
Cyp8b1  (cytochrome P450 family 8 subfamily B member 1)
Nr1h4  (nuclear receptor subfamily 1, group H, member 4)

Genes (Mus musculus)
Abcc4  (ATP-binding cassette, sub-family C member 4)
Cyp27a1  (cytochrome P450, family 27, subfamily a, polypeptide 1)
Cyp7a1  (cytochrome P450, family 7, subfamily a, polypeptide 1)
Cyp8b1  (cytochrome P450, family 8, subfamily b, polypeptide 1)
Nr1h4  (nuclear receptor subfamily 1, group H, member 4)

Genes (Homo sapiens)
ABCC4  (ATP binding cassette subfamily C member 4 (PEL blood group))
CYP27A1  (cytochrome P450 family 27 subfamily A member 1)
CYP7A1  (cytochrome P450 family 7 subfamily A member 1)
CYP8B1  (cytochrome P450 family 8 subfamily B member 1)
NR1H4  (nuclear receptor subfamily 1 group H member 4)


Additional Information